Elixir Medical Corp., reported positive 12-month results for its Dynamx Coronary Bioadaptor System, with no target vessel revascularization (TVR) or stent thrombosis and adaptive remodeling of the ...
PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that ...
PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced outstanding 12-month data for the DynamX™ Coronary Bioadaptor System, the first ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...
A unique metallic DES that “uncages” the artery and allows for positive adaptive remodeling has shown solid findings through 1 year in a small study of patients with single de novo coronary lesions, ...
PARIS, Nov. 2, 2011—Arterial Remodeling Technologies (“ART”) reported today that in vivo data strongly suggest that its second-generation bioresorbable stent promotes positive arterial remodeling in a ...
Cardiac stents have transformed the landscape of cardiovascular medicine, providing a less invasive and highly effective means to treat coronary artery disease. What is a stent? A cardiac stent is a ...
There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...
During a heart angioplasty, a doctor uses a catheter with a balloon to open a narrowed blood vessel in the heart. Typically, they insert a stent during the procedure. A stent is a mesh tube designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results